Assessment of Naples prognostic score in predicting survival for small cell lung cancer patients treated with chemoradiotherapy.

Backgrounds: The Naples prognosis score (NPS) is a novel prognostic biomarker-based immune and nutritional status and that can be used to evaluate prognosis. Our study aimed to investigate the prognostic role of NPS in SCLC patients.

Methods: Patients treated with chemoradiotherapy were retrospectively analyzed between June 2012 and August 2017.